EU-OPENSCREEN

EU-OPENSCREEN integrates high-capacity screening platforms throughout Europe, which jointly use a rationally selected compound collection, comprising up to 140.000 commercial and proprietary compounds collected from European chemists. EU-OPENSCREEN offers to researchers from academic institutions, SMEs and industrial organisations open access to its shared resources. EU-OPENSCREEN will collaboratively develop novel molecular tool compounds with external users from various disciplines of the life sciences

High-throughput screening ,fragment based library screening,virtual screening,bioprofiling,european chemical biology database (ecbd),compound collection,medicinal chemistry,and project funding

Eu-openscreen operates in the Research industry.

Eu-openscreen's revenue is 11m - 100m

Eu-openscreen has 11 - 50 employees.